The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to provide an environment that will foster communication and collaboration between investigator communities involved in complications research. The DiaComp-PTP will provide investigators with access to pilot funds to pursue additional preclinical studies of promising new therapeutics.
|Notice of Intent to Publish a Notice of Funding Opportunity for Diabetes Research Centers (P30 Clinical Trial Optional)
|This Notice encourages investigators with expertise and insights into diabetes, its complications, and related endocrine and metabolic diseases to begin to consider applying for this new NOFO to establish or continue a Diabetes Research Center (DRC). Estimated Publication Date of Notice of Funding Opportunity : March 01, 2024.
|Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
|This Notice of Funding Opportunity (NOFO) welcomes applications for the Consortium on Modeling Autoimmune Diabetes (CMAD) that supports the development of in vitro and in vivo models of type 1 diabetes (T1D) to enable studies of human T1D pathophysiology and to serve as platforms for preclinical assessments of new T1D interventions.